Chi‐Kuei Hsu

529 total citations
25 papers, 322 citations indexed

About

Chi‐Kuei Hsu is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Chi‐Kuei Hsu has authored 25 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Neurology. Recurrent topics in Chi‐Kuei Hsu's work include COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (7 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Chi‐Kuei Hsu is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (7 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Chi‐Kuei Hsu collaborates with scholars based in Taiwan and China. Chi‐Kuei Hsu's co-authors include Chih‐Cheng Lai, Po‐Ren Hsueh, Muh‐Yong Yen, Wen‐Chien Ko, Ping‐Ing Lee, Chien‐Ming Chao, Likwang Chen, Jiun‐Ting Wu, Shun‐Hsing Hung and Wei‐Ting Lin and has published in prestigious journals such as PLoS ONE, BMJ Open and Alzheimer s & Dementia.

In The Last Decade

Chi‐Kuei Hsu

21 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Kuei Hsu Taiwan 9 110 88 86 81 74 25 322
Andreas Lind Norway 11 205 1.9× 91 1.0× 72 0.8× 70 0.9× 83 1.1× 32 383
Vijay Harypursat China 12 289 2.6× 75 0.9× 92 1.1× 119 1.5× 54 0.7× 41 452
Federica Frasca Italy 13 165 1.5× 69 0.8× 73 0.8× 70 0.9× 21 0.3× 43 363
Daniel Hornuß Germany 9 152 1.4× 75 0.9× 63 0.7× 58 0.7× 17 0.2× 24 359
Santhamani Ramasamy United States 9 220 2.0× 84 1.0× 126 1.5× 87 1.1× 36 0.5× 25 418
Chuan Song China 10 197 1.8× 35 0.4× 130 1.5× 111 1.4× 49 0.7× 37 444
Andrea Mastrángelo Italy 10 170 1.5× 35 0.4× 60 0.7× 78 1.0× 100 1.4× 21 380
Amandine Pisoni France 12 292 2.7× 30 0.3× 50 0.6× 113 1.4× 26 0.4× 29 475
Vincenzo Malagnino Italy 13 203 1.8× 59 0.7× 61 0.7× 188 2.3× 56 0.8× 53 450
Jovan Ranin Serbia 12 196 1.8× 31 0.4× 66 0.8× 166 2.0× 124 1.7× 49 469

Countries citing papers authored by Chi‐Kuei Hsu

Since Specialization
Citations

This map shows the geographic impact of Chi‐Kuei Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Kuei Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Kuei Hsu more than expected).

Fields of papers citing papers by Chi‐Kuei Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Kuei Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Kuei Hsu. The network helps show where Chi‐Kuei Hsu may publish in the future.

Co-authorship network of co-authors of Chi‐Kuei Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Kuei Hsu. A scholar is included among the top collaborators of Chi‐Kuei Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Kuei Hsu. Chi‐Kuei Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hsu, Chi‐Kuei, et al.. (2024). Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region. International Journal of Antimicrobial Agents. 64(2). 107205–107205. 9 indexed citations
3.
Lai, Chung-Hsu, et al.. (2024). Validity of urinary catheter specimens for diagnosis of urinary tract infection in patients with short-term catheterization. Diagnostic Microbiology and Infectious Disease. 110(4). 116536–116536.
4.
Huang, Po‐Yu, et al.. (2024). Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications. Expert Review of Anti-infective Therapy. 22(6). 387–398. 7 indexed citations
5.
Tsai, Ya‐Wen, Jheng‐Yan Wu, Tinghui Liu, et al.. (2024). Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients. Frontiers in Public Health. 12. 1337646–1337646. 1 indexed citations
6.
Hsu, Chi‐Kuei & Chih‐Cheng Lai. (2024). Analysis of semaglutide's effect on Alzheimer's disease risk. Alzheimer s & Dementia. 21(2). e14462–e14462.
7.
Lan, Shao‐Huan, Chi‐Kuei Hsu, Shen-Peng Chang, Li‐Chin Lu, & Chih‐Cheng Lai. (2023). Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Annals of Medicine. 55(1). 2208872–2208872. 4 indexed citations
8.
Hsu, Wan‐Hsuan, Chi‐Kuei Hsu, & Chih‐Cheng Lai. (2023). Ceftobiprole medocaril for the treatment of pneumonia. Expert Review of Anti-infective Therapy. 21(6). 551–563. 5 indexed citations
9.
Huang, Po‐Yu, Chi‐Kuei Hsu, Jheng‐Yan Wu, et al.. (2023). Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance. 33. 201–207. 3 indexed citations
10.
Hsu, Chi‐Kuei, et al.. (2023). Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials. International Journal of Antimicrobial Agents. 62(2). 106844–106844. 6 indexed citations
11.
Lai, Chih‐Cheng, Chi‐Kuei Hsu, Muh‐Yong Yen, et al.. (2022). Long COVID: An inevitable sequela of SARS-CoV-2 infection. Journal of Microbiology Immunology and Infection. 56(1). 1–9. 84 indexed citations
12.
Lan, Shao‐Huan, Chi‐Kuei Hsu, Chih‐Cheng Lai, et al.. (2022). Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials. Annals of Medicine. 54(1). 1956–1965. 5 indexed citations
13.
Hsu, Chi‐Kuei, et al.. (2022). Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials. International Journal of Antimicrobial Agents. 59(3). 106545–106545. 12 indexed citations
14.
Hsu, Chi‐Kuei, Chien‐Ming Chao, & Chih‐Cheng Lai. (2022). Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis. Journal of Microbiology Immunology and Infection. 55(6). 1129–1130. 3 indexed citations
15.
Chen, Ching‐Yi, et al.. (2022). The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Journal of Infection and Public Health. 15(8). 896–901. 5 indexed citations
16.
Hsu, Chi‐Kuei, et al.. (2021). Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. International Immunopharmacology. 99. 108027–108027. 20 indexed citations
17.
18.
Hsu, Chi‐Kuei, et al.. (2016). Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study. PeerJ. 4. e2753–e2753. 19 indexed citations
19.
Lai, Chung‐Hsu, Lin‐Li Chang, Weifang Chen, et al.. (2014). Clinical Characteristics of Q Fever and Etiology of Community-Acquired Pneumonia in a Tropical Region of Southern Taiwan: A Prospective Observational Study. PLoS ONE. 9(7). e102808–e102808. 12 indexed citations
20.
Hsu, Chi‐Kuei, Li-Chen Yen, Der‐An Tsao, et al.. (2009). The KRAS Mutation is Highly Correlated With EGFR Alterations in Patients With Non-small Cell Lung Cancer. 1(2). 65–71. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Lind Breakdown of academic impact, for papers by Vijay Harypursat Breakdown of academic impact, for papers by Federica Frasca Breakdown of academic impact, for papers by Daniel Hornuß Breakdown of academic impact, for papers by Santhamani Ramasamy Breakdown of academic impact, for papers by Chuan Song Breakdown of academic impact, for papers by Andrea Mastrángelo Breakdown of academic impact, for papers by Amandine Pisoni Breakdown of academic impact, for papers by Vincenzo Malagnino Breakdown of academic impact, for papers by Jovan Ranin
Rankless by CCL
2026